Drug Profile
ALD 201
Alternative Names: ALD-201Latest Information Update: 13 Apr 2016
Price :
$50
*
At a glance
- Originator Aldagen
- Class Stem cell therapies
- Mechanism of Action Angiogenesis inducing agents; Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Ischaemic heart disorders